Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for AbbVie
Company Monitoring Page for AbbVie
latest headlines for company on cafepharma
AbbVie, Roche to seek broader market for leukemia drug after trial success
BioPharma Dive
Tue, 09/19/17 - 10:23 pm
Tags:
AbbVie
,
Roche
,
clinical trials
,
Venclexta
,
Rituxan
,
chronic lymphocytic leukemia
Which of These 5 Will Be the Best-Selling Drug Worldwide in 2020?
Motley Fool
Sat, 09/16/17 - 12:01 pm
Tags:
AbbVie
,
Humira
,
Celgene
,
Revlimid
,
Bristol-Myers Squibb
,
Opdivo
,
Merck
,
Keytruda
,
Biogen
,
aducanumab
AbbVie keen on JAK inhibitor despite safety concerns
BioPharma Dive
Tue, 09/12/17 - 04:22 pm
Tags:
AbbVie
,
JAK inhibitors
,
Upadacitinib
,
ABT-494
,
rheumatoid arthritis
AbbVie and Pfizer hover at top, J&J Stelara surges in August TV pharma ad spend
Fierce Pharma
Mon, 09/11/17 - 09:06 pm
Tags:
AbbVie
,
Pfizer
,
JNJ
,
drug ads
,
television ads
AbbVie reports two patient deaths in rheumatoid arthritis study
Yahoo/Reuters
Mon, 09/11/17 - 09:25 am
Tags:
AbbVie
,
clinical trials
,
rheumatoid arthritis
,
Upadacitinib
,
ABT-494
AbbVie preps JAK atopic dermatitis candidate for phase 3
Fierce Biotech
Sun, 09/10/17 - 11:56 am
Tags:
AbbVie
,
JAK inhibitors
,
clinical trials
,
atopic dermatitis
,
Upadacitinib
,
Sanofi
,
Regeneron
,
Dupixent
This Shield of Patents Protects the World’s Best-Selling Drug
Bloomberg
Fri, 09/8/17 - 09:25 am
Tags:
patents
,
AbbVie
,
Humira
AbbVie adds more stellar data on ABT-494 — this time for atopic dermatitis
Endpoints
Thu, 09/7/17 - 09:46 am
Tags:
AbbVie
,
ABT-494
,
atopic dermatitis
,
Upadacitinib
Infographic | The leaders of the global hepatitis-C market
Medical Marketing and Media
Thu, 08/31/17 - 09:27 am
Tags:
hepatitis C
,
Gilead Sciences
,
Merck
,
AbbVie
,
Bristol-Myers Squibb
Pharma Stocks That Could Move On New Data
Barron's
Sat, 08/26/17 - 07:36 pm
Tags:
pharma stocks
,
AbbVie
,
Bayer
,
Novartis
,
Bristol-Myers Squibb
,
Eli Lilly
,
European Society of Cardiology
Biogen, Samsung Humira copy wins EU approval
Fierce Pharma
Fri, 08/25/17 - 09:52 am
Tags:
Biogen
,
Samsung Bioepis
,
Europe
,
Humira
,
AbbVie
,
Imraldi
,
biosimilars
The decade's top 10 patent losses, worth a whopping $915B in lifetime sales
Fierce Pharma
Thu, 08/17/17 - 10:36 am
Tags:
patents
,
AbbVie
,
Humira
,
Pfizer
,
Lipitor
,
Norvasc
,
GSK
,
Advair
,
Sanofi
,
Lantus
,
JNJ
,
Remicade
,
AstraZeneca
,
Crestor
,
Nexium
,
Amgen
,
Neulasta
,
Novartis
,
Diovan
The 2017 report card so far: Big Biotech largely trading up as pharma posts mixed results
Fierce Pharma
Thu, 08/10/17 - 06:58 pm
Tags:
pharma stocks
,
Merck
,
Pfizer
,
AbbVie
,
Eli Lilly
,
Bristol-Myers Squibb
,
GSK
,
Roche
,
Sanofi
,
Bayer
,
Novo Nordisk
,
Celgene
,
Biogen
,
AstraZeneca
AbbVie’s new, cheaper hepatitis C drug could launch the drug world’s own Hunger Games
Marketwatch
Sun, 08/6/17 - 09:48 pm
Tags:
AbbVie
,
hepatitis C
,
Mavyret
,
Gilead Sciences
,
Merck
Is AbbVie About to Deliver a Blow to Gilead Sciences' Guidance?
Motley Fool
Sat, 08/5/17 - 09:44 am
Tags:
AbbVie
,
Gilead Sciences
,
hepatitis C
,
Mavyret
AbbVie's new pan-genotypic hepatitis C drug Mavyret deeply underprices the competition
Fierce Pharma
Fri, 08/4/17 - 11:32 am
Tags:
AbbVie
,
hepatitis C
,
Mavyret
,
drug pricing
J&J, AbbVie's Imbruvica breaks out of blood-cancer corner with new graft-versus-host approval
Fierce Pharma
Wed, 08/2/17 - 09:33 pm
Tags:
JNJ
,
AbbVie
,
Imbruvica
,
graft vs host disease
,
FDA
AbbVie confident in strategy as Humira mints money
BioPharma Dive
Sat, 07/29/17 - 09:44 am
Tags:
AbbVie
,
Humira
AbbVie scores surprisingly good Q2 results but pipeline worries persist
Fierce Pharma
Fri, 07/28/17 - 10:42 pm
Tags:
AbbVie
,
earnings
Gilead Sciences Has 3 Available Options, but Only 1 Makes Sense
Motley Fool
Thu, 07/27/17 - 09:47 am
Tags:
Gilead Sciences
,
AbbVie
,
hepatitis C
,
reorganization
Pages
« first
‹ previous
…
40
41
42
43
44
45
46
47
48
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
a dog would most likely chase a: cat, rock, house
*
Fill in the blank.